A guideline published today by the Dutch College of General Practitioners states that physicians should consider administering ‘low molecular weight heparin’ to patients with (high suspicion of) Covid-19 as a precaution. Heparin is a drug used to prevent or treat blood clots.
It specifically concerns people who are bedridden and have a history of a deep vein thrombosis (DVT) or pulmonary embolism.
Deep vein thrombosis
Venous thrombosis is when a blood clot blocks a vein (a vein), explains the Thrombosis Foundation. This often happens in the legs. A clot from the leg or abdominal cavity can break off and enter the lungs. That is called pulmonary embolism. A clot can also form in the lungs, also called a pulmonary embolism. A DVT develops in the deeper veins.
It is the first time that general practitioners have prescribed medicines to risk groups to prevent serious consequences of a Covid-19 infection, the NOS reports. In total, it would be about 150,000 to 200,000 people.
–
–
Research among 184 corona patients in intensive care in Dutch hospitals shows that half of them experience thrombosis symptoms. Patients who suffer from it are more likely to die.
–
–
